In laryngeal squamous cell carcinoma, HOTAIR sponges hsa-miR-30a-5p, thereby relieving the inhibition of its target GRP78 (HSPA5), which subsequently leads to increased PD-L1 protein levels (Yuan et al., 2022). Here, HSPA5 is linked to laryngeal squamous cell carcinoma.